Emcure Pharmaceuticals Q1 FY27 reports 22.8% revenue growth to ₹25,804 million, while PAT jumps 36.2% and EBITDA rises 25.8% in Q1 FY27.
Read MoreQuarterly Results
Wipro Q1 FY27: Revenue Rises 0.9% YoY in Constant Currency; Large Deal Bookings Reach $1.6 Billion
Wipro Q1 FY27 results show 0.9% YoY constant currency revenue growth, $1.6 billion in large deal bookings, robust cash flow and ₹2 interim dividend.
Read More